The European Pharmaceutical Law Review focuses on legal and regulatory aspects of medicinal products within the European Union. Articles examine patent rights, parallel imports, and access to medicines, as well as the legal frameworks for artificial intelligence in healthcare and health data spaces. The journal also covers marketing authorization procedures, foreign direct investment in the pharmaceutical industry, and the legal implications of vaccination campaigns.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2017
2018
2019
2020
2021
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
LawQ3
Drug DiscoveryQ4
Pharmaceutical ScienceQ4
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q4
Subject Classification
Scopus Categories
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)LawDrug DiscoveryPharmaceutical Science
Research Topics (OpenAlex)
Pharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of LifeInternational Arbitration and Investment LawScience, Research, and MedicineConflict of Laws and JurisdictionIntellectual Property and PatentsInternational Law and AviationBiomedical Ethics and RegulationEuropean and International Law StudiesLaw, AI, and Intellectual Property